|
|
||||||||
1-antitrypsin deficiency in COPD patients
1 Dept of Pneumology, Institut Clínic del Tòrax, Hospital Clínic (IDIBAPS), Red Respira (FIS-ISCIII-RTIC-03/11), and 2 Depts of Biochemistry and 3 Pneumology, Hospital Vall d'Hebron, Barcelona, Spain.
CORRESPONDENCE: M. Miravitlles, Dept of Pneumology, Hospital Clínic, C/ Villarroel 170 (UVIR, esc 2, planta 3), Barcelona 08036, Spain. Fax: 34 932275549. E-mail: marcm{at}clinic.ub.es
Keywords:
1-Antitrypsin deficiency, chronic obstructive pulmonary disease, diagnosis, genetics
Received: January 20, 2005
Accepted July 1, 2005
The first phase analysed samples from 971 patients by determining
A total of eight (0.37%) individuals with the severe deficiency PiZZ were detected. In addition, three patients were identified with the PiSZ genotype in the second phase (0.3%). The global cost of the programme was \#8364;41,512, which represents \#8364;19.42 per sample and \#8364;5,189 per PiZZ detected. A sensitivity analysis demonstrated that performing Z genotype to all samples would have resulted in increased costs of \#8364;28 per sample and \#8364;7,479.5 per PiZZ case identified.
In conclusion, a case detection programme of
1-Antitrypsin (
1-AT) deficiency is an underdiagnosed condition in patients with chronic obstructive pulmonary disease (COPD). The present authors have conducted a nationwide case detection programme of
1-AT deficiency in unselected patients with COPD using dried blood spots.
1-AT concentrations and identifying the deficient Z allele by genotyping using rapid real-time PCR. The second phase analysed 1,166 samples with
1-AT concentrations and identified both the S and the Z allele, but only in samples with low
1-AT concentrations.
1-antitrypsin deficiency in patients with chronic obstructive pulmonary disease using dried blood spots is feasible and at a reasonable cost per case detected. Diagnostic yield and costs depend largely on inclusion criteria and the protocol for processing of samples.
This article has been cited by other articles:
![]() |
G. Tirado-Conde, B. Lara, and M. Miravitlles Augmentation therapy for emphysema due to alpha-1-antitrypsin deficiency Therapeutic Advances in Respiratory Disease, February 1, 2008; 2(1): 13 - 21. [Abstract] [PDF] |
||||
![]() |
J. Stolk Case detection of {alpha}1-antitrypsin deficiency: does it help the patient or the doctor? Eur. Respir. J., October 1, 2005; 26(4): 561 - 562. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |